People · Operator
Named in public records as an officer, director or promoter · active 2012–2021 · Healthtech, Biotechnology, Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Quartet Health, Inc. | — | Healthtech | Series C | $127.0M | $1.4B | 2016 |
| Verve Therapeutics, Inc. | — | Biotechnology | Series C | $94.0M | $3.1B | 2021 |
| PatientPing, Inc. | — | Other Health Care | Series B | $41.4M | $701.2M | 2015 |
| Dnanexus, Inc. | — | Biotechnology | Series A | $31.6M | $542.3M | 2013 |
| Flatiron Health, Inc. | — | Other Technology | Series A | $8.0M | $221.9M | 2012 |
Krishna Yeshwant at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Krishna Yeshwant on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Goldberg | 1 | 11 |
| Arun Gupta | 1 | 10 |
| Jon Lim | 1 | 9 |
| ROB HAYES | 1 | 9 |
| Ann Lamont | 1 | 9 |
| Carl Byers | 1 | 7 |
| Geoff Duyk | 1 | 5 |
| Doug Williams | 1 | 5 |
| Steve Shulman | 1 | 5 |
| Puneet Singh | 1 | 4 |
| Stephen Thau | 1 | 4 |
| Patrick Kennedy | 1 | 4 |
| John Evans | 1 | 4 |
| Richard Daly | 1 | 3 |
| Ken Goulet | 1 | 2 |
| Jay Desai | 1 | 2 |
| Andrew Bellinger | 1 | 2 |
| Nat Turner | 1 | 2 |
| Lindsey Anido | 1 | 2 |
| Sharyn Alcaraz | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.